Skip to Main Content

Paper Details

Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.
PLoS Comput Biol
2
2023
COVID-19, OC43, OC43 coronavirus, RNA, SARS, SARS-, SARS-CoV, SARS-CoV-, SARS-CoV-2, SARS-CoV-2 infected cells, Simvastatin, Statins, Vero E6 cells, atorvastatin, cultured human cells, drug, endothelial cells, human, human endothelial cells, infected cells, patient, patients, simvastatin, statins
Author NameAffiliation
James LogueUniversity of Maryland School of Medicine
Holly HammondUniversity of Maryland School of Medicine
Matthew B FriemanUniversity of Maryland School of Medicine
Matthew B FriemanUniversity of Maryland School of Medicine
  • 1 - 4

Datasets

Release 1.2